# Shandong Cancer Hospital Affiliated to Shandong University

> **NCT02958033** · PHASE3 · UNKNOWN · sponsor: **Shandong Cancer Hospital and Institute** · enrollment: 100 (estimated)

## Conditions studied

- Early-stage Breast Cancer
- Breast Conserving Surgery

## Interventions

- **RADIATION:** Whole Breast irradiation Plus simultaneous tumor bed Boost

## Key facts

- **NCT ID:** NCT02958033
- **Lead sponsor:** Shandong Cancer Hospital and Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11
- **Primary completion:** 2019-11
- **Final completion:** 2024-11
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2016-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02958033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02958033, "Shandong Cancer Hospital Affiliated to Shandong University". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT02958033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*